Demetra acquires Maxxspine Innovative GmbH, strengthening its position in spine surgery

[April 28, 2026] – Demetra announces the successful completion of the acquisition of Maxxspine Innovative GmbH, a German-based company specialized in advanced spinal surgery solutions. The transaction further strengthens Demetra’s position as a benchmark international group in spine surgery.

The acquisition has been completed by Osartis GmbH, a Demetra Group company, which has acquired 100% ownership and full control of Maxxspine Innovative GmbH, effective as of today.

Founded in Germany and established in 2010, Maxxspine is recognized for the development and distribution of cutting-edge medical devices for spinal surgery, with a strong presence in the German market and a growing international footprint. Through this acquisition, Demetra significantly expands its spine portfolio and reinforces its proximity to surgeons and healthcare professionals in key European markets and beyond.

For over 40 years, Demetra has been a trusted partner to healthcare professionals worldwide, improving the lives of more than three million patients through advanced solutions in infection control, prosthesis fixation, orthobiologics and minimally invasive surgery. Operating through established companies such as Tecres, Osartis and OsteoRemedies, Demetra continues to invest in innovation, people and long-term sustainable growth.

Following the completion of the transaction, Osartis will take global responsibility for Maxxspine’s activities and will work closely with the existing management and teams over the coming months to ensure a smooth integration and continuity for customers and partners.

“Becoming part of a strong and ambitious international group like Demetra provides the ideal platform to further develop what I have built over the years. This step makes me proud of our journey so far and confident in the results we can achieve together, with Maxxspine’s values of trust and professionalism fully respected and carried forward.”
Volker Ludwig, CEO of Maxxspine Innovation

Positioning for growth in the EU and beyond

“The acquisition of Maxxspine is fully aligned with Demetra’s strategy to strengthen its presence in the key European spine surgery markets. By integrating highly specialised companies like Maxxspine, we further enhance our ability to stay close to surgeons and patients, delivering innovative solutions and reinforcing our role as a trusted international partner in spine care.”
Michele Perrino, CEO of Demetra